SCANGOS GEORGE A 1202102 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | acq | 1750000.0 | 100.0 | 130.35 | 0.0 | The Spouse Of The Reporting Person | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 1750000.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | dsp | 3500000.0 | 99.05 | 260.71 | 0.0 | See Footnote F2 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 33629.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | dsp | 111644.0 | 100.0 | 8.32 | 0.0 | See Footnote F4 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 0.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | dsp | 827151.0 | 100.0 | 61.61 | 0.0 | See Footnote F7 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 0.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | dsp | 111644.0 | 100.0 | 8.32 | 0.0 | See Footnote F6 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 0.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | holding | 179930.0 | 0 | 13.4 | 0.0 | See Footnote F8 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.25 (VIR) | ||
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | dsp | 827151.0 | 100.0 | 61.61 | 0.0 | See Footnote F5 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 0.0 | 134.25 (VIR) |
| 2023-09-18 | 2023-09-15 | 2023-09-15 | 4 | Scangos George A | DIRECTOR | acq | 1750000.0 | 91.22 | 130.35 | 0.0 | Direct | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 1918489.0 | 134.25 (VIR) |
| 2023-10-18 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | holding | 179930.0 | 0 | 13.4 | 0.0 | See Footnote F6 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.25 (VIR) | ||
| 2023-10-18 | 2023-10-17 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | acq | 1750000.0 | 100.0 | 130.35 | 0.0 | See Footnote F2 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 1750000.0 | 134.25 (VIR) |
| 2023-10-18 | 2023-10-17 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | dsp | 1750000.0 | 100.0 | 130.35 | 0.0 | The Spouse Of The Reporting Person | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 0.0 | 134.25 (VIR) |
| 2023-10-18 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | holding | 33629.0 | 0 | 2.5 | 0.0 | See Footnote F5 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.25 (VIR) | ||
| 2023-10-18 | 2023-10-17 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | acq | 1750000.0 | 100.0 | 130.35 | 0.0 | See Footnote F4 | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 1750000.0 | 134.25 (VIR) |
| 2023-10-18 | 2023-10-17 | 2023-10-17 | 4 | Scangos George A | DIRECTOR | dsp | 1750000.0 | 91.22 | 130.35 | 0.0 | Direct | Common Stock | VIR BIOTECHNOLOGY, INC. | code J | 168489.0 | 134.25 (VIR) |
| 2024-02-20 | 2024-02-16 | 4 | Scangos George A | DIRECTOR | holding | 1750000.0 | 0 | 130.09 | 0.0 | See Footnote F4 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-20 | 2024-02-16 | 4 | Scangos George A | DIRECTOR | holding | 33629.0 | 0 | 2.5 | 0.0 | See Footnote F6 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-20 | 2024-02-16 | 4 | Scangos George A | DIRECTOR | holding | 1750000.0 | 0 | 130.09 | 0.0 | See Footnote F5 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-20 | 2024-02-16 | 4 | Scangos George A | DIRECTOR | holding | 179930.0 | 0 | 13.38 | 0.0 | See Footnote F7 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-20 | 2024-02-16 | 2024-02-16 to 2024-02-20 | 4 | Scangos George A | DIRECTOR | dsp | 27750.0 | 16.47 | 2.06 | 10.23 | Direct | Common Stock | VIR BIOTECHNOLOGY, INC. | code S | 140739.0
|
134.52 (VIR) |
| 2024-02-26 | 2024-02-22 | 4 | Scangos George A | DIRECTOR | holding | 179930.0 | 0 | 13.38 | 0.0 | See Footnote F7 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-26 | 2024-02-22 | 4 | Scangos George A | DIRECTOR | holding | 1750000.0 | 0 | 130.09 | 0.0 | See Footnote F4 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-26 | 2024-02-22 | 4 | Scangos George A | DIRECTOR | holding | 1750000.0 | 0 | 130.09 | 0.0 | See Footnote F5 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-26 | 2024-02-22 | 4 | Scangos George A | DIRECTOR | holding | 33629.0 | 0 | 2.5 | 0.0 | See Footnote F6 | Common Stock | VIR BIOTECHNOLOGY, INC. | NA | 134.52 (VIR) | ||
| 2024-02-26 | 2024-02-22 | 2024-02-22 to 2024-02-26 | 4 | Scangos George A | DIRECTOR | dsp | 27750.0 | 19.72 | 2.06 | 11.07 | Direct | Common Stock | VIR BIOTECHNOLOGY, INC. | code S | 112989.0
|
134.52 (VIR) |
| 2024-03-19 | 2024-03-15 | 2024-03-15 | 4 | Scangos George A | DIRECTOR | acq | 1678.0 | 7.63 | 0.06 | 147.48 | Direct | Common Stock | AGILENT TECHNOLOGIES, INC. | code A | 21989.355 | 293.06 (A) |
| 2024-03-19 | 2024-03-15 | 4 | Scangos George A | DIRECTOR | holding | 14450.0 | 0 | 0.49 | 0.0 | George A. Scangos And Leslie S. Wilson Family Trust | Common Stock | AGILENT TECHNOLOGIES, INC. | NA | 293.06 (A) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-11 | 2023-05-09 | 2023-05-09 | 4 | Scangos George A | DIRECTOR | acq | 44000.0 | 100.0 | 10.11 | 10.76 | Direct | Stock Option (Right To Buy) | VOYAGER THERAPEUTICS, INC. | code A | 44000.0 | 43.54 (VYGR) |
| 2023-06-07 | 2023-06-06 | 2023-06-06 | 4 | Scangos George A | DIRECTOR | acq | 22000.0 | 100.0 | 5.05 | 12.57 | Direct | Stock Option (Right To Buy) | VOYAGER THERAPEUTICS, INC. | code A | 22000.0 | 43.54 (VYGR) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)